Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing-Reference-Cited by-同舟云学术

Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing

Published:2016-12-17 Issue:7 Volume:8 Page:11460-11479
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Selt Florian¹²,Hohloch Juliane¹,Hielscher Thomas³,Sahm Felix⁴⁵,Capper David⁴⁵,Korshunov Andrey⁴⁵,Usta Diren¹,Brabetz Sebastian⁶,Ridinger Johannes¹,Ecker Jonas¹²,Oehme Ina¹,Gronych Jan⁷⁸,Marquardt Viktoria⁹,Pauck David⁹,Bächli Heidi¹⁰,Stiles Charles D.¹¹,von Deimling Andreas⁴⁵,Remke Marc⁹,Schuhmann Martin U.¹²,Pfister Stefan M.²⁶,Brummer Tilman¹³,Jones David T.W.⁶,Witt Olaf¹²,Milde Till¹²

Affiliation:

1. Clinical Cooperation Unit Pediatric Oncology (G340), German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany

2. Center for Individualized Pediatric Oncology (ZIPO) and Section of Pediatric Brain Tumors, Department of Pediatric Oncology, Hematology and Immunology, University Hospital Heidelberg, Heidelberg, Germany

3. Division of Biostatistics (C060), German Cancer Research Center (DKFZ), Heidelberg, Germany

4. Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany

5. Clinical Cooperation Unit Neuropathology (G380), German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany

6. Division of Pediatric Neurooncology (B062), German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Heidelberg, Germany

7. Division of Molecular Genetics (B060), German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany

8. AbbVie Deutschland GmbH & Co. KG, Medical Immunology, Wiesbaden, Germany (current affiliation)

9. Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Germany, and Department of Pediatric Neuro-Oncogenomics, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

10. Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany

11. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA

12. Department of Neurosurgery, University Hospital Tübingen, Tübingen, Germany

13. Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University and University Medical Centre, Freiburg, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissecting the Natural Patterns of Progression and Senescence in Pediatric Low-Grade Glioma: From Cellular Mechanisms to Clinical Implications;Cells;2024-07-19

2. MOST wanted: navigating the MAPK-OIS-SASP-tumor microenvironment axis in primary pediatric low-grade glioma and preclinical models;Child's Nervous System;2024-05-25

3. Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines;Journal of Neuro-Oncology;2024-04-17

4. Pediatric low-grade glioma models: advances and ongoing challenges;Frontiers in Oncology;2024-01-22

5. KIAA1549-BRAF Gene Fusion Spindle Cell Sarcoma With Infantile Fibrosarcoma-Like Pattern in a Pediatric Patient: A Case Report;Cureus;2024-01-09